Your session is about to expire
← Back to Search
Procedure
Cholangioscopy for Gallstone Disease
N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 minutes to 2.5 hours anticipated time frame
Awards & highlights
Summary
Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP for non-complex bile duct stone disease.
Eligible Conditions
- Gallstone Disease
- Biliary Obstruction
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 30 weeks post-procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 weeks post-procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Stone clearance
Secondary outcome measures
Procedure Duration
Other outcome measures
Adverse Events
Trial Design
1Treatment groups
Experimental Treatment
Group I: CholangioscopyExperimental Treatment2 Interventions
Participants in this arm undergo radiation-free ERCP facilitated by cholangioscopy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cholangioscopy
2015
N/A
~40
Spyglass DS Cholangioscope
2015
N/A
~40
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,448 Previous Clinical Trials
17,492,354 Total Patients Enrolled
Boston Scientific CorporationIndustry Sponsor
737 Previous Clinical Trials
854,196 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger